CMP Scientific & Agilent to advance capillary electrophoresis–mass spectrometry solutions

19 October 2022 | News

Strategic collaborations between CMP and Agilent in last five years have generated great values to both companies

image credit- shutterstock

image credit- shutterstock

CMP Scientific Corp. has signed a global co-marketing agreement with Agilent Technologies to provide an integrated capillary electrophoresis–mass spectrometry (CE-MS) solution to life science and pharmaceutical industry.

CMP and Agilent will work together to implement new applications for the CE-MS system, which is a sensitive, alternative method to liquid chromatography-mass spectrometry (LC-MS) in mapping biological components.

One of CMP’s major products, EMASS-II CE-MS ion source integrates seamlessly with the Agilent’s MS instruments to identify therapeutic monoclonal antibody (mAb) charge variants, and to analyze other diverse biological molecules.

CMP first introduced the EMASS-II CE-MS, which utilizes an electrokinetically pumped nanospray sheath liquid interface to provide reliable and robust performance, in 2015. Leading biopharmaceutical companies now routinely use the EMASS-II CE-MS ion source in high sensitivity applications ranging from mAb intact mass analysis, charge variant analysis, CE-SDS impurity analysis, subunit analysis, peptide mapping analysis, biosimilar comparisons to preclinical biotransformation studies. This interface has also been globally employed for metabolite analysis, nucleic acid analysis and polysaccharide analysis.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account